GridAI Technologies (GRDX) Research & Development (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Research & Development came in at $893402.0 in Q4 2025, up 4071.07% YoY from $21419.0 in Q4 2024, and up 13288.31% on a QoQ basis from $6673.0 in Q3 2025.
GridAI Technologies (GRDX) Research & Development (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Research & Development data on file, last reported at $893402.0 in Q4 2025.
- Quarterly Research & Development rose 4071.07% year-over-year to $893402.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $926533.0 (down 7.59% YoY) and the FY2025 annual result came in at $925482.0, up 2.38% from the prior year.
- Research & Development grew to $893402.0 in Q4 2025, from $6673.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $5.8 million in Q4 2021 to a low of -$3.2 million in Q4 2023.
- A 5-year average of $1.4 million and a median of $842234.5 in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development slumped 3268.11% — and 2025, when it jumped 4071.07%.
- Tracing GRDX's Research & Development over 5 years: stood at $5.8 million in 2021, then sank by 98.24% to $101822.0 in 2022, then tumbled by 3268.11% to -$3.2 million in 2023, then surged by 100.66% to $21419.0 in 2024, then jumped by 4071.07% to $893402.0 in 2025.
- The last three Research & Development figures came in at $893402.0 (Q4 2025), $6673.0 (Q3 2025), and $10631.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 413.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 210.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 97.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -588.31 Mn |
| 10 | GridAI Technologies | 6.06 Mn | 6.06 Mn | - | 895,673.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 893,402.00 |
| Sep 30, 2025 | 6,673.00 |
| Jun 30, 2025 | 10,631.00 |
| Mar 31, 2025 | 15,827.00 |
| Dec 31, 2024 | 21,419.00 |
| Sep 30, 2024 | 206,999.00 |
| Jun 30, 2024 | 219,591.00 |
| Mar 31, 2024 | 554,662.00 |
| Dec 31, 2023 | -3.23 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 1.35 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 101,822.00 |
| Sep 30, 2022 | 791,067.00 |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | 4.98 Mn |
| Dec 31, 2021 | 5.78 Mn |
| Sep 30, 2021 | 3.05 Mn |
| Jun 30, 2021 | 5.65 Mn |
| Mar 31, 2021 | 2.52 Mn |